VCM
BCRX icon

Virtue Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Virtue Capital Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-59,973
Closed -$975K – 291
2022
Q1 		$975K Buy
+59,973
New +$975K 0.15% 165